HK1245679A1 - Methods and compositions for treating dermatological diseases and conditions - Google Patents

Methods and compositions for treating dermatological diseases and conditions Download PDF

Info

Publication number
HK1245679A1
HK1245679A1 HK18105517.3A HK18105517A HK1245679A1 HK 1245679 A1 HK1245679 A1 HK 1245679A1 HK 18105517 A HK18105517 A HK 18105517A HK 1245679 A1 HK1245679 A1 HK 1245679A1
Authority
HK
Hong Kong
Prior art keywords
skin
dhe
transdermal composition
isoeugenol
active agent
Prior art date
Application number
HK18105517.3A
Other languages
English (en)
Chinese (zh)
Inventor
Bryan B Fuller
Original Assignee
Therametics, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therametics, Llc filed Critical Therametics, Llc
Publication of HK1245679A1 publication Critical patent/HK1245679A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
HK18105517.3A 2007-10-10 2011-04-29 Methods and compositions for treating dermatological diseases and conditions HK1245679A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US99834507P 2007-10-10 2007-10-10
US60/998,345 2007-10-10
US12647808P 2008-05-05 2008-05-05
US61/126,478 2008-05-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK11104291.5A Addition HK1150155B (en) 2007-10-10 2008-10-10 Topical compositions for treating inflammatory disorders, diseases and conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK11104291.5A Division HK1150155B (en) 2007-10-10 2008-10-10 Topical compositions for treating inflammatory disorders, diseases and conditions

Publications (1)

Publication Number Publication Date
HK1245679A1 true HK1245679A1 (en) 2018-08-31

Family

ID=40549597

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18105517.3A HK1245679A1 (en) 2007-10-10 2011-04-29 Methods and compositions for treating dermatological diseases and conditions

Country Status (5)

Country Link
EP (2) EP2244690B1 (enExample)
JP (1) JP5570992B2 (enExample)
CA (3) CA3006143C (enExample)
HK (1) HK1245679A1 (enExample)
WO (1) WO2009049172A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616006B2 (en) 2007-10-10 2017-04-11 DermaMedics, LLC Methods and compositions for treating dermatological diseases and conditions
JP5596444B2 (ja) * 2010-07-07 2014-09-24 花王株式会社 抗炎症剤の評価又は選択方法
FR2973230B1 (fr) * 2011-04-01 2013-11-01 Oreal Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau
FI3777876T3 (fi) 2011-10-28 2023-10-18 Neostrata Company Inc N-asyylidipeptidijohdannaisia ja niiden käyttöjä
DE102013204088A1 (de) * 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch relevanten Duftstoffen
KR101914844B1 (ko) * 2013-10-24 2018-11-02 더 프록터 앤드 갬블 캄파니 피부 미백 화장 조성물 및 방법
US20190298688A1 (en) * 2016-11-21 2019-10-03 Vivier Canada Inc. Putrescine slow-release topical formulations
JP7047997B2 (ja) * 2017-12-21 2022-04-05 ポーラ化成工業株式会社 組成物
JP7356228B2 (ja) * 2018-01-31 2023-10-04 株式会社コーセー 組成物
WO2020180311A1 (en) * 2019-03-06 2020-09-10 Zen-Bio, Inc. Plant-based exosome compositions and use thereof for rejuvenating skin
WO2020205539A1 (en) * 2019-03-29 2020-10-08 Vizuri Health Sciences Consumer Healthcare, Inc. Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers
WO2022122122A1 (en) * 2020-12-08 2022-06-16 Symrise Ag Medicament for fighting inflammatory conditions of human skin (i)
WO2022128054A1 (en) * 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)
WO2022128051A1 (en) * 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (ii)
CN114588139A (zh) * 2022-03-16 2022-06-07 中国农业大学 乙基香兰素在制备抗皮肤光损伤产品中的用途
CN118078795A (zh) * 2024-02-28 2024-05-28 首都医科大学附属北京友谊医院 乙酸异丁香酚酯在制备预防和/或治疗炎症性肠病的药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3909816A (en) 1974-04-29 1975-09-30 Lloyd L Teeters Flame and carbon monoxide sensor and alarm circuit
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4983396A (en) 1985-12-06 1991-01-08 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
US4886783A (en) 1986-01-31 1989-12-12 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4801586A (en) 1986-04-23 1989-01-31 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US5118845A (en) 1986-09-29 1992-06-02 Whitby Research, Inc. Penetration enhancer for transdermal delivery of systemic agents
US5196410A (en) 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
FR2829696B1 (fr) * 2001-09-17 2004-02-27 Oreal Utilisation de l'acide pantetheine sulfonique et/ou de ses sels en tant qu'agent anti-radicalaire
IL161545A0 (en) * 2001-11-16 2004-09-27 Cutanix Corp Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
DE20221578U1 (de) * 2001-12-07 2006-06-08 Hoenzelaer, Norbert Vorrichtung und Pflaster zur kontrollierten Freisetzung von Vanillin
SE0201880D0 (sv) * 2002-06-19 2002-06-19 Milenca Gardovic Komposition för att behandla hudåkommor och för att förbättra hårtillväxt
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20060229347A1 (en) * 2005-03-30 2006-10-12 Astion Development A/S Treatment of eczemas
US20070207220A1 (en) * 2006-03-01 2007-09-06 Kathryn Luedtke Method for improving sleep behaviors

Also Published As

Publication number Publication date
EP2244690A4 (en) 2011-03-23
WO2009049172A1 (en) 2009-04-16
JP2011500597A (ja) 2011-01-06
CA2740200A1 (en) 2009-04-16
CA3006143C (en) 2021-10-19
CA2866527A1 (en) 2009-04-16
CA2740200C (en) 2015-01-13
EP2244690B1 (en) 2017-08-02
CA3006143A1 (en) 2009-04-16
EP2244690A1 (en) 2010-11-03
EP3238696A1 (en) 2017-11-01
CA2866527C (en) 2018-07-03
JP5570992B2 (ja) 2014-08-13

Similar Documents

Publication Publication Date Title
CA2740200C (en) Methods and compositions for treating dermatological diseases and conditions
US10869822B2 (en) Compositions for treatment of dermatological diseases and conditions and methods of use thereof
EP1441685B1 (en) Compositions for anti-irritating rosacea treatment
CN1547475B (zh) 含电子转移试剂的磷酸酯衍生物的皮肤制剂
Putra et al. Skin changes and safety profile of topical products during pregnancy
KR20190101948A (ko) 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물
US20100247693A1 (en) Cosmetic formulation to treat rosacea telangiectasia
US10052297B2 (en) L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
WO1996014085A1 (en) External preparation for skin protection
KR20020027198A (ko) 염증과 홍반의 완화방법
US10596090B2 (en) Cosmetic formulation to reduce facial flushing
WO2001045697A1 (en) Skin external agents and drugs
US7763263B2 (en) Skin external agents and drugs
HK1150155A (en) Topical compositions for treating inflammatory disorders, diseases and conditions
HK1150155B (en) Topical compositions for treating inflammatory disorders, diseases and conditions
JP2006298796A (ja) 小じわ改善用皮膚外用剤
ES2645535T3 (es) Composiciones tópicas para tratar trastornos, enfermedades y dolencias inflamatorios
KR100789344B1 (ko) 올리고뉴클레오타이드를 포함하는 피부 노화 방지제
TW200900089A (en) Cosmetic preparations designed to reduce unsightly cellulite